Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 31;20(1):128.
doi: 10.3390/ijms20010128.

Etiology of Metabolic Syndrome and Dietary Intervention

Affiliations
Review

Etiology of Metabolic Syndrome and Dietary Intervention

Hang Xu et al. Int J Mol Sci. .

Abstract

The growing prevalence of metabolic syndrome (MetS) in the U.S. and even worldwide is becoming a serious health problem and economic burden. MetS has become a crucial risk factor for the development of type 2 diabetes mellitus (T2D) and cardiovascular diseases (CVD). The rising rates of CVD and diabetes, which are the two leading causes of death, simultaneously exist. To prevent the progression of MetS to diabetes and CVD, we have to understand how MetS occurs and how it progresses. Too many causative factors interact with each other, making the investigation and treatment of metabolic syndrome a very complex issue. Recently, a number of studies were conducted to investigate mechanisms and interventions of MetS, from different aspects. In this review, the proposed and demonstrated mechanisms of MetS pathogenesis are discussed and summarized. More importantly, different interventions are discussed, so that health practitioners can have a better understanding of the most recent research progress and have available references for their daily practice.

Keywords: dietary intervention; insulin resistance; metabolic syndrome; obesity; personal nutrition.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The role of kinases in the insulin signaling cascades and its interaction with nutrients in control of FOXO1-mediated physiological function. AA—amino acids; FFA—free fatty acids; HGP—hepatic glucose production; Agt—angiotensinogen; Hmox-1—heme oxygenase-1; G6pc—glucose-6-phosphatase catalytic subunit; Agrp—agouti-related peptide; pY—tyrosine phosphorylation; pS/T—serine/threonine phosphorylation; OGT—O-GlcNAc transferase; HBP—hexosamine biosynthetic pathway; PIP2—phosphatidylinositol-4,5-biphosphate; PIP3—phosphatidylinositol-3,4,5-triphosphate; PTP1B—protein tyrosine phosphatase; PTEN—phosphatase and tensin homolog; PDK—phosphoinositide-dependent protein kinase; PI3K—phosphatidylinositide 3-kinase; PIKKs—PI3K-related kinase family; IR—insulin receptor.

Similar articles

Cited by

References

    1. Reaven G.M. Role of Insulin Resistance in Human Disease. Diabetes. 1988;37:1595–1607. doi: 10.2337/diab.37.12.1595. - DOI - PubMed
    1. Gallagher E.J., LeRoith D., Karnieli E. The metabolic syndrome—From insulin resistance to obesity and diabetes. Endocrinol. Metab. Clin. N. Am. 2008;37:559–579. doi: 10.1016/j.ecl.2008.05.002. - DOI - PubMed
    1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C., Jr., et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. - PubMed
    1. Reaven G.M. The metabolic syndrome: Is this diagnosis necessary ? Am. J. Clin. Nutr. 2006;83:1237–1247. doi: 10.1093/ajcn/83.6.1237. - DOI - PubMed
    1. Ogden C.L., Carroll M.D., Fryar C.D., Flegal K.M. Prevalence of Obesity Among Adults and Youth: United States, 2011–2014. NCHS Data Brief. 2015;219:1–8. - PubMed